Nov. 5, 2024 /PRNewswire-PRWeb/ -- BioFactura, Inc. recently announced contract option activations totaling $7.8 million by the Biomedical Advanced Research and Development ... completed activities ...

Research Grid, the AI startup that helps medical research institutions automate back-office admin for clinical trials, has ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...

Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.

Glaukos Corporation GKOS reported third-quarter 2024 adjusted loss of 28 cents per share, surpassing the Zacks Consensus ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.